FINHUB Insights

CAH · Q3 FY25 · Jan 1 – Mar 31, 2025

Cardinal Health Q3 FY25: where the revenue came from and where it went

Cardinal Health Q3 FY25: revenue $54.9B (+0% year over year). Net profit $0.5B. Largest cohort Pharmaceutical and Specialty $50.4B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jan 1 – Mar 31, 2025
Reported
May 1, 2025 10-Q
Sankey diagram of Cardinal Health's income statement for Q3 FY25: revenue of $54.9 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$54.9B +0% year over year
Gross profit$2.1B 4% margin
Operating profit$0.7B 1% margin
Net profit$0.5B 1% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Mar 31, 2025).
ItemValueShare of revenueYear over year
Revenue 54.9 100% +0%
Pharmaceutical and Specialty 50.4 92% +0%
GMPD 3.2 6% +2%
All Other Segments 1.3 2% +13%
Cost of revenue−52.896%
Gross profit2.14% margin+0pp
SG&A−1.32%+0pp
Other−0.10%+0pp
Operating profit0.71% margin+1pp
Tax−0.1
Interest & other costs−0.1
Net profit0.51%+0pp
Filing on EDGAR More quarters of CAH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters